MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation

Sean S Park, John L. Chunta, John M. Robertson, Alvaro A. Martinez, Ching Yee Oliver Wong, Mitual Amin, George D. Wilson, Brian Marples

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: Glioblastoma multiforme (GBM) is an aggressive tumor that typically causes death due to local progression. To assess a novel low-dose radiotherapy regimen for treating GBM, we developed an orthotopic murine model of human GBM and evaluated in vivo treatment efficacy using micro-positron- emission tomography/computed tomography (microPET/CT) tumor imaging. Methods: Orthotopic GBM xenografts were established in nude mice and treated with standard 2-Gy fractionation or 10 0.2-Gy pulses with 3-min interpulse intervals, for 7 consecutive days, for a total dose of 14 Gy. Tumor growth was quantified weekly using the Flex Triumph (GE Healthcare/Gamma Medica-Ideas, Waukesha, WI) combined PET-single-photon emission CT (SPECT)-CT imaging system and necropsy histopathology. Normal tissue damage was assessed by counting dead neural cells in tissue sections from irradiated fields. Results: Tumor engraftment efficiency for U87MG cells was 86%. Implanting 0.5 × 106 cells produced a 50- to 70-mm3 tumor in 10 to 14 days. A significant correlation was seen between CT-derived tumor volume and histopathology-measured volume (p = 0.018). The low-dose 0.2-Gy pulsed regimen produced a significantly longer tumor growth delay than standard 2-Gy fractionation (p = 0.045). Less normal neuronal cell death was observed after the pulsed delivery method (p = 0.004). Conclusion: This study successfully demonstrated the feasibility of in vivo brain tumor imaging and longitudinal assessment of tumor growth and treatment response with microPET/CT. Pulsed radiation treatment was more efficacious than the standard fractionated treatment and was associated with less normal tissue damage.

Original languageEnglish (US)
Pages (from-to)885-892
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume80
Issue number3
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Glioblastoma
tumors
dosage
irradiation
evaluation
Neoplasms
tomography
Growth
death
fractionation
positrons
cells
pulsed radiation
damage
Tumor Burden
Photons
Heterografts
Nude Mice
Neuroimaging
Brain Neoplasms

Keywords

  • Glioma
  • Hyper-radiosensitivity
  • Low dose
  • Orthotopic tumor

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. / Park, Sean S; Chunta, John L.; Robertson, John M.; Martinez, Alvaro A.; Oliver Wong, Ching Yee; Amin, Mitual; Wilson, George D.; Marples, Brian.

In: International Journal of Radiation Oncology Biology Physics, Vol. 80, No. 3, 01.07.2011, p. 885-892.

Research output: Contribution to journalArticle

Park, Sean S ; Chunta, John L. ; Robertson, John M. ; Martinez, Alvaro A. ; Oliver Wong, Ching Yee ; Amin, Mitual ; Wilson, George D. ; Marples, Brian. / MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. In: International Journal of Radiation Oncology Biology Physics. 2011 ; Vol. 80, No. 3. pp. 885-892.
@article{7c0831ff304e4c29a417a36b11b87842,
title = "MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation",
abstract = "Purpose: Glioblastoma multiforme (GBM) is an aggressive tumor that typically causes death due to local progression. To assess a novel low-dose radiotherapy regimen for treating GBM, we developed an orthotopic murine model of human GBM and evaluated in vivo treatment efficacy using micro-positron- emission tomography/computed tomography (microPET/CT) tumor imaging. Methods: Orthotopic GBM xenografts were established in nude mice and treated with standard 2-Gy fractionation or 10 0.2-Gy pulses with 3-min interpulse intervals, for 7 consecutive days, for a total dose of 14 Gy. Tumor growth was quantified weekly using the Flex Triumph (GE Healthcare/Gamma Medica-Ideas, Waukesha, WI) combined PET-single-photon emission CT (SPECT)-CT imaging system and necropsy histopathology. Normal tissue damage was assessed by counting dead neural cells in tissue sections from irradiated fields. Results: Tumor engraftment efficiency for U87MG cells was 86{\%}. Implanting 0.5 × 106 cells produced a 50- to 70-mm3 tumor in 10 to 14 days. A significant correlation was seen between CT-derived tumor volume and histopathology-measured volume (p = 0.018). The low-dose 0.2-Gy pulsed regimen produced a significantly longer tumor growth delay than standard 2-Gy fractionation (p = 0.045). Less normal neuronal cell death was observed after the pulsed delivery method (p = 0.004). Conclusion: This study successfully demonstrated the feasibility of in vivo brain tumor imaging and longitudinal assessment of tumor growth and treatment response with microPET/CT. Pulsed radiation treatment was more efficacious than the standard fractionated treatment and was associated with less normal tissue damage.",
keywords = "Glioma, Hyper-radiosensitivity, Low dose, Orthotopic tumor",
author = "Park, {Sean S} and Chunta, {John L.} and Robertson, {John M.} and Martinez, {Alvaro A.} and {Oliver Wong}, {Ching Yee} and Mitual Amin and Wilson, {George D.} and Brian Marples",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.ijrobp.2011.01.045",
language = "English (US)",
volume = "80",
pages = "885--892",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation

AU - Park, Sean S

AU - Chunta, John L.

AU - Robertson, John M.

AU - Martinez, Alvaro A.

AU - Oliver Wong, Ching Yee

AU - Amin, Mitual

AU - Wilson, George D.

AU - Marples, Brian

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Purpose: Glioblastoma multiforme (GBM) is an aggressive tumor that typically causes death due to local progression. To assess a novel low-dose radiotherapy regimen for treating GBM, we developed an orthotopic murine model of human GBM and evaluated in vivo treatment efficacy using micro-positron- emission tomography/computed tomography (microPET/CT) tumor imaging. Methods: Orthotopic GBM xenografts were established in nude mice and treated with standard 2-Gy fractionation or 10 0.2-Gy pulses with 3-min interpulse intervals, for 7 consecutive days, for a total dose of 14 Gy. Tumor growth was quantified weekly using the Flex Triumph (GE Healthcare/Gamma Medica-Ideas, Waukesha, WI) combined PET-single-photon emission CT (SPECT)-CT imaging system and necropsy histopathology. Normal tissue damage was assessed by counting dead neural cells in tissue sections from irradiated fields. Results: Tumor engraftment efficiency for U87MG cells was 86%. Implanting 0.5 × 106 cells produced a 50- to 70-mm3 tumor in 10 to 14 days. A significant correlation was seen between CT-derived tumor volume and histopathology-measured volume (p = 0.018). The low-dose 0.2-Gy pulsed regimen produced a significantly longer tumor growth delay than standard 2-Gy fractionation (p = 0.045). Less normal neuronal cell death was observed after the pulsed delivery method (p = 0.004). Conclusion: This study successfully demonstrated the feasibility of in vivo brain tumor imaging and longitudinal assessment of tumor growth and treatment response with microPET/CT. Pulsed radiation treatment was more efficacious than the standard fractionated treatment and was associated with less normal tissue damage.

AB - Purpose: Glioblastoma multiforme (GBM) is an aggressive tumor that typically causes death due to local progression. To assess a novel low-dose radiotherapy regimen for treating GBM, we developed an orthotopic murine model of human GBM and evaluated in vivo treatment efficacy using micro-positron- emission tomography/computed tomography (microPET/CT) tumor imaging. Methods: Orthotopic GBM xenografts were established in nude mice and treated with standard 2-Gy fractionation or 10 0.2-Gy pulses with 3-min interpulse intervals, for 7 consecutive days, for a total dose of 14 Gy. Tumor growth was quantified weekly using the Flex Triumph (GE Healthcare/Gamma Medica-Ideas, Waukesha, WI) combined PET-single-photon emission CT (SPECT)-CT imaging system and necropsy histopathology. Normal tissue damage was assessed by counting dead neural cells in tissue sections from irradiated fields. Results: Tumor engraftment efficiency for U87MG cells was 86%. Implanting 0.5 × 106 cells produced a 50- to 70-mm3 tumor in 10 to 14 days. A significant correlation was seen between CT-derived tumor volume and histopathology-measured volume (p = 0.018). The low-dose 0.2-Gy pulsed regimen produced a significantly longer tumor growth delay than standard 2-Gy fractionation (p = 0.045). Less normal neuronal cell death was observed after the pulsed delivery method (p = 0.004). Conclusion: This study successfully demonstrated the feasibility of in vivo brain tumor imaging and longitudinal assessment of tumor growth and treatment response with microPET/CT. Pulsed radiation treatment was more efficacious than the standard fractionated treatment and was associated with less normal tissue damage.

KW - Glioma

KW - Hyper-radiosensitivity

KW - Low dose

KW - Orthotopic tumor

UR - http://www.scopus.com/inward/record.url?scp=79957571056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957571056&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2011.01.045

DO - 10.1016/j.ijrobp.2011.01.045

M3 - Article

C2 - 21489704

AN - SCOPUS:79957571056

VL - 80

SP - 885

EP - 892

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -